NCT01398462 Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients Status COMPLETED Phase PHASE1
NCT01369498 Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis Status COMPLETED Phase PHASE2
NCT01340651 Study of Ruxolitinib (INCB018424) Sustained Release Formulation in Myelofibrosis Patients Status COMPLETED Phase PHASE2
NCT01317875 Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF) Status COMPLETED Phase PHASE1
NCT01300611 TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation Status TERMINATED Phase PHASE1
NCT01290302 Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza Status COMPLETED Phase PHASE1
NCT01149681 Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis Status COMPLETED Phase PHASE2
NCT00997386 Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States Status COMPLETED Phase PHASE2
NCT00975975 Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer Status COMPLETED Phase PHASE2
NCT00934544 Controlled Myelofibrosis Study With Oral Janus-associated Kinase (JAK) Inhibitor Treatment-II: The COMFORT-II Trial Status COMPLETED Phase PHASE3
NCT00852709 Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias Status TERMINATED Phase PHASE1
NCT00807677 A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies Status COMPLETED Phase PHASE1
NCT00745550 A Phase 1/2 Study of Oral SB1518 in Subjects With Chronic Idiopathic Myelofibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00724334 A Long-Term Study of the Effects of Orally Administered SAR302503 in Patients With Myelofibrosis Status COMPLETED Phase PHASE1/PHASE2
NCT00719888 Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease Status COMPLETED Phase PHASE2
NCT00719836 A Phase 1/2 Study of SB1518 for the Treatment of Advanced Myeloid Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT00715247 Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes Status COMPLETED Phase N/A